table of content
Table of Contents
Chapter 1 Measles, Mumps & Rubella (MMR) Vaccines Market Overview
1.1 Measles, Mumps & Rubella (MMR) Vaccines Definition
1.2 Global Measles, Mumps & Rubella (MMR) Vaccines Market Size Status and Outlook (2018-2032)
1.3 Global Measles, Mumps & Rubella (MMR) Vaccines Market Size Comparison by Region (2018-2032)
1.4 Global Measles, Mumps & Rubella (MMR) Vaccines Market Size Comparison by Type (2018-2032)
1.5 Global Measles, Mumps & Rubella (MMR) Vaccines Market Size Comparison by Application (2018-2032)
1.6 Global Measles, Mumps & Rubella (MMR) Vaccines Market Size Comparison by Sales Channel (2018-2032)
1.7 Measles, Mumps & Rubella (MMR) Vaccines Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Merger/Acquisition/Expansion)
1.7.4 Key Trends in Measles, Mumps & Rubella (MMR) Vaccines Market
Chapter 2 Measles, Mumps & Rubella (MMR) Vaccines Market Competition by Player
2.1 Global Measles, Mumps & Rubella (MMR) Vaccines Sales and Market Share by Player (2021-2023)
2.2 Global Measles, Mumps & Rubella (MMR) Vaccines Revenue and Market Share by Player (2021-2023)
2.3 Global Measles, Mumps & Rubella (MMR) Vaccines Average Price by Player (2021-2023)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Measles, Mumps & Rubella (MMR) Vaccines Market Segment by Type
3.1 Global Measles, Mumps & Rubella (MMR) Vaccines Market by Type
3.1.1 Monovalent Vaccine
3.1.2 Polyvalent Vaccine
3.2 Global Measles, Mumps & Rubella (MMR) Vaccines Sales and Market Share by Type (2018-2023)
3.3 Global Measles, Mumps & Rubella (MMR) Vaccines Revenue and Market Share by Type (2018-2023)
3.4 Global Measles, Mumps & Rubella (MMR) Vaccines Average Price by Type (2018-2023)
3.5 Conclusion of Segment by Type
Chapter 4 Measles, Mumps & Rubella (MMR) Vaccines Market Segment by Application
4.1 Global Measles, Mumps & Rubella (MMR) Vaccines Market by Application
4.1.1 Children
4.1.2 Adults
4.2 Global Measles, Mumps & Rubella (MMR) Vaccines Revenue and Market Share by Application (2018-2023)
4.3 Conclusion of Segment by Application
Chapter 5 Measles, Mumps & Rubella (MMR) Vaccines Market Segment by Sales Channel
5.1 Global Measles, Mumps & Rubella (MMR) Vaccines Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Measles, Mumps & Rubella (MMR) Vaccines Revenue and Market Share by Sales Channel (2018-2023)
5.3 Conclusion of Segment by Sales Channel
Chapter 6 Measles, Mumps & Rubella (MMR) Vaccines Market Segment by Region & Country
6.1 Global Measles, Mumps & Rubella (MMR) Vaccines Market Size and CAGR by Region (2018-2032)
6.2 Global Measles, Mumps & Rubella (MMR) Vaccines Sales and Market Share by Region (2018-2023)
6.3 Global Measles, Mumps & Rubella (MMR) Vaccines Revenue and Market Share by Region (2018-2023)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Measles, Mumps & Rubella (MMR) Vaccines Market Share by Type
6.4.3 North America Measles, Mumps & Rubella (MMR) Vaccines Market Share by Application
6.4.4 United States
6.4.5 Canada
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Measles, Mumps & Rubella (MMR) Vaccines Market Share by Type
6.5.3 Europe Measles, Mumps & Rubella (MMR) Vaccines Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Spain
6.5.9 Russia
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Measles, Mumps & Rubella (MMR) Vaccines Market Share by Type
6.6.3 Asia-Pacific Measles, Mumps & Rubella (MMR) Vaccines Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Measles, Mumps & Rubella (MMR) Vaccines Market Share by Type
6.7.3 South America Measles, Mumps & Rubella (MMR) Vaccines Market Share by Application
6.7.4 Brazil
6.7.5 Mexico
6.7.6 Argentina
6.7.7 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Measles, Mumps & Rubella (MMR) Vaccines Market Share by Type
6.8.3 Middle East & Africa Measles, Mumps & Rubella (MMR) Vaccines Market Share by Application
6.8.4 Turkey
6.8.5 UAE
6.8.6 Saudi Arabia
6.8.7 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Measles, Mumps & Rubella (MMR) Vaccines Players
7.1 Medlmmune
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Johnson & Johnson
7.3 Merck
7.4 Sanofi
7.5 GlaxoSmithKline
7.6 Pfizer
7.7 CSL
7.8 Serum
7.9 Bavarian Nordic
7.10 Astellas Pharma
7.11 Emergent BioSolutions
7.12 Sinopharm
Chapter 8 Upstream and Downstream Analysis of Measles, Mumps & Rubella (MMR) Vaccines
8.1 Industrial Chain of Measles, Mumps & Rubella (MMR) Vaccines
8.2 Upstream of Measles, Mumps & Rubella (MMR) Vaccines
8.3 Downstream of Measles, Mumps & Rubella (MMR) Vaccines
Chapter 9 Development Trend of Measles, Mumps & Rubella (MMR) Vaccines (2024-2032)
9.1 Global Measles, Mumps & Rubella (MMR) Vaccines Market Size (Sales and Revenue) Forecast (2024-2032)
9.2 Global Measles, Mumps & Rubella (MMR) Vaccines Market Size and CAGR Forecast by Region (2024-2032)
9.3 Global Measles, Mumps & Rubella (MMR) Vaccines Market Size and CAGR Forecast by Type (2024-2032)
9.4 Global Measles, Mumps & Rubella (MMR) Vaccines Market Size and CAGR Forecast by Application (2024-2032)
9.5 Global Measles, Mumps & Rubella (MMR) Vaccines Market Size and CAGR Forecast by Sales Channel (2024-2032)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
